Delivery Order SPE2DX22D0010-SPE2D826FAD16
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,205.75 firm fixed-price delivery order by the Defense Logistics Agency on June 2, 2025, for Nucynta ER 200 mg tablets (60-count supply). The contract, which carries an ultimate completion date of June 3, 2025, represents a non-competitive award and serves the federal medical supply chain supporting military and veteran healthcare systems. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 20, 2025, by the Defense Logistics Agency to supply 100 tablets of Nucynta 50 mg, a prescription opioid pain medication. This firm fixed-price delivery order, valued at $2,450.08, is a non-set-aside contract with an ultimate completion date of August 21, 2025, and represents a child order under the company's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,305.19 by the Medical Supply Chain, a Defense Logistics Agency entity, on September 16, 2025, with an ultimate completion date of September 17, 2025. The contract involves delivery of Nucynta ER Tabs 200mg, an extended-release opioid pain medication, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract value of $1,990.55. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,380.43 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is non-competitive and carries an ultimate completion date of August 5, 2025. The award reflects AmerisourceBergen's established role as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,731.14 by the Defense Logistics Agency's Medical Supply Chain on July 5, 2025. This firm fixed-price, non-set-aside contract has an ultimate completion date of July 7, 2025, and represents a child order under a larger indefinite delivery contract vehicle. The award reflects the contractor's ongoing role as a critical federal medical procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,158.40 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,532.40 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, carries an ultimate completion date of August 22, 2025 and involves no set-aside designation. The award represents a competitively awarded transaction consistent with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on October 2, 2025, with a ceiling value of $299,260.29. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency's Medical Supply Chain and is set to be completed by October 3, 2025. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,514.52 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, with an ultimate completion date of August 29, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAD16Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on October 6, 2025, for Nucynta ER Tabs 100mg with a ceiling value of $5,338.16. This firm fixed price delivery order, with an ultimate completion date of October 7, 2025, was competitively awarded without set-aside provisions to support the Defense Logistics Agency's Medical Supply Chain. The contract represents a continuation of AmerisourceBergen's substantial role as a critical federal pharmaceutical vendor, particularly for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience delivering a diverse range of pharmaceutical products, including specialty medications, generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 10/6/25 |